Meeting Notice - North Dakota Medicaid Drug Use Review Board (Sept. 4, 2024)

<< All Events
Start: Wednesday, September 4, 2024 - 01:00 pm
End: Wednesday, September 4, 2024 - 04:00 pm Categories:
Public Notices

North Dakota Medicaid Drug Use Review Board
Wednesday, Sept. 4, 2024
1:00 - 4:00 p.m. CST

In-Person Information 
Conference Room 210/212, 2nd Floor, Judicial Wing, State Capitol 600 E. Boulevard Ave, Bismarck, ND 58505

Virtual Information
Join by computer: Click here to join the meeting 
Join by phone: 701-328-0950, Conference ID: 506 213 519#

Agenda

  • Call to Order
  • Roll Call
  • Review and Approval of Minutes
  • Reports from Department
    • Administrative Report
    • Financial Report: Top Drugs
    • Retrospective DUR Report
    • Clinical Report:
      • Prior Authorization Update
        • Criteria updates: asthma/COPD, chronic kidney disease, Duchenne muscular dystrophy, growth hormone, heart failure, hereditary angioedema, hypertrophic cardiomyopathy, lipid-lowering treatment, plaque psoriasis, medications over$3000, dry eye disease
  • Unfinished Business
  • New Business 
    • Second Review of Molluscum Contagiosum (Ycanth and Zelsuvmi)
    • Second Review of Epidermolysis Bullosa (Filsuvez)
    • Second Review of Metabolic Dysfunction–Associated Steatohepatitis (Rezdiffra)
    • First Review of Attention-Deficit Hyperactivity Disorder Stimulants
    • Review of retrospective DUR criteria recommendations
    • Announcements: Next Meeting (December 4, 2024)
    • Adjourn

 

Individuals with disabilities who need accommodations, including appropriate auxiliary aids to participate, can contact Ashley Gerving at 701-328-2354, toll-free 800-755-2604, 711 (TTY) or gervingashley@nd.gov.

Date Posted: Jan. 18, 2024
Date Revised: Aug. 6, 2024 (agenda/meeting details added)

<< All Events
Navigate to Event